Skip to main content
Clinical Trials/NCT04465006
NCT04465006
Completed
Not Applicable

Efficacy of Hippotherapy Simulator Exercise Program in Stroke Patients

Marmara University1 site in 1 country26 target enrollmentDecember 1, 2018
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
Marmara University
Enrollment
26
Locations
1
Primary Endpoint
Rivermead Mobility Index
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of our study is to investigate the effects of hippotherapy simulator exercises in addition to the conventional rehabilitation program on the balance, postural control, mobility, functional capacity, and independence levels of stroke patients.

Detailed Description

Twenty-six 18- 65 years of patients with stroke were included in the study. Patients were divided into two groups as hippotherapy simulator group (HSG) (n = 13) and conventional exercise group (CEG) (n = 13). Patients were evaluated with Berg Balance Scale (BBS) for balance, Postural Assessment Scale for Stroke (PASS) for postural control, Rivermead Mobility Index (RMI), and Time Up- Go Test (TUG) for mobility, 2min. Walking Test (2mWT) for functional capacity and Barthel Index (BI) for the level of independence respectively before and after treatment.

Registry
clinicaltrials.gov
Start Date
December 1, 2018
End Date
May 30, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Getting a diagnosis of stroke by a specialist physician,
  • Being between the ages of 18-65,
  • Having a stroke history of 3- 36 months,
  • To be able to sit without support while both soles are in contact with the floor,
  • To be able to walk independently with or without using a walking aid,
  • To be able to understand and follow audio and visual warnings,
  • Scoring 24 points or more from the Mini-Mental State Exam.

Exclusion Criteria

  • Multiple stroke stories,
  • Hemorrhagic type stroke history,
  • Those with a history of falling in the past 1 year,
  • Those with a history of epilepsy,
  • Uncontrolled history of Hypertension and Diabetes

Outcomes

Primary Outcomes

Rivermead Mobility Index

Time Frame: Day 0 - Day 45

The Rivermead Mobility Index assesses functional mobility in gait, balance and transfers after stroke.

Timed Up and Go Test

Time Frame: Day 0 - Day 45

The Timed Up and Go (TUG) test is a performance-based measure of functional mobility that was initially developed to identify mobility and balance impairments in older adults.

2 Minute Walk Test

Time Frame: Day 0 - Day 45

2 Minute Walk Test (2MWT) is a measure of self-paced walking ability and functional capacity.

Berg Balance Scale

Time Frame: Day 0 - Day 45

The Berg balance scale is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete.

Postural Assessment Scale for Stroke

Time Frame: Day 0 - Day 45

It measures the ability of an individual with stroke to maintain stable postures and equilibrium during positional changes. It consists of a 4-point scale where the items are scored from 0 to 3, and the total scoring ranges from 0 to 36

Barthel Index

Time Frame: Day 0 - Day 45

The Barthel Scale/Index (BI) is an ordinal scale used to measure performance in activities of daily living (ADL).

Study Sites (1)

Loading locations...

Similar Trials